Colorectal Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps.
|
8416989 |
1993 |
Colorectal Carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
However, it is clear that, as with the abnormal expression pattern of CD44 variant exons, intron 9 retention is a good-candidate molecular diagnostic tool for colorectal carcinomas.
|
7545538 |
1995 |
Colorectal Carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The results of this study show that mutant p53 protein and variant v6 of the CD44 glycoprotein are markers of tumour progression in colorectal cancer.
|
7534253 |
1995 |
Colorectal Carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Identification of CD44 splice variant in Korean colorectal cancers and cell lines.
|
8527042 |
1995 |
Colorectal Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
These findings indicated that this domain of the CD44 glycoprotein encoded by exons v8-10 may play an important role in tumor hematogenous metastasis of human colorectal cancer.
|
7538103 |
1995 |
Colorectal Carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Expression of a CD44 variant containing exons 8 to 10 is a useful independent factor for the prediction of prognosis in colorectal cancer patients.
|
8648366 |
1996 |
Colorectal Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
CD44 exon variant 6 epitope and hyaluronate synthase are expressed on HT29 human colorectal carcinoma cells in a SCID mouse model of metastasis formation.
|
8605724 |
1996 |
Colorectal Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Alternatively spliced variants of the cell adhesion molecule CD44 and tumour progression in colorectal cancer.
|
8695347 |
1996 |
Colorectal Carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Cellular distribution of CD44 gene transcripts in colorectal carcinomas and in normal colonic mucosa.
|
8763263 |
1996 |
Colorectal Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
The expression of CD44-mRNA was examined in 90 specimens from 44 patients with colorectal cancer or colorectal adenomatous polyps and in the peripheral blood leukocytes from 7 healthy volunteers by reverse transcription-polymerase chain reaction and Southern blot hybridization.
|
8566581 |
1996 |
Colorectal Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Abnormal expression of the variant exons and of intron 9 of the CD44 gene in tumour cells exfoliated into the colonic lumen may be helpful markers for the early, non-invasive, diagnosis of colorectal cancer.
|
8655705 |
1996 |
Colorectal Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
The overexpression of such abnormal CD44 variants was observed from an early stage in colorectal cancer and did not correlate with nodal or distant metastatic status.
|
8608952 |
1996 |
Colorectal Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Deranged CD44 gene activity in colorectal cancer cells is confirmed.
|
9117309 |
1997 |
Colorectal Carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
CD44 splice variants as prognostic markers in colorectal cancer.
|
9489913 |
1998 |
Colorectal Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Clinical significance of serum levels of CD44 variant exons 8-10 protein in colorectal cancer.
|
9658313 |
1998 |
Colorectal Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Using a new set of primers for exon-specific reverse transcription-polymerase chain reaction (RT-PCR) we delineated the exact exon composition of CD44 mRNAs in normal colorectal mucosa, including isolated colonic crypts, in colorectal carcinomas and in their hepatic metastases.
|
9849461 |
1998 |
Colorectal Carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Here we report a functional role for CD44 variant isoforms in colorectal cancer metastasis.
|
9721884 |
1998 |
Colorectal Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
The aim of this study was to evaluate whether CD44 isoform expression is a prognostic factor in gastric and colorectal cancer.
|
9839501 |
1998 |
Colorectal Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Multivariate analysis demonstrated that CD44 expression and lymph node metastasis in gastric cancer and CD44 and sialyl Lea expression in colorectal cancer were significantly related to hepatic metastasis.
|
9772282 |
1998 |
Colorectal Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
The aim of this study was to investigate abnormal expression of the CD44 gene in exfoliated cells from patients with colorectal cancer.
|
9609756 |
1998 |
Colorectal Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Decreased expression of CD44 splicing variants in advanced colorectal carcinomas.
|
9893637 |
1998 |
Colorectal Carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Based on the important role of CD44 splice variants in colorectal cancer progression and metastasis, we evaluated the use of CD44v6 expression to detect and assess the metastatic potential of colorectal tumour cells circulating in peripheral blood.
|
10755402 |
2000 |
Colorectal Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
The significance of CD44 variants expression in colorectal cancer and its regional lymph nodes.
|
11194197 |
2000 |
Colorectal Carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The current results suggest that the up-regulation of CD44 variant 6 through nuclear beta-catenin activation may contribute to the formation of tumor budding, and immunostaining of these two adhesion molecules may be useful in identifying those at high-risk for locoregional failure among patients with T1 colorectal carcinoma.
|
11745187 |
2001 |
Colorectal Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
This study is the first to demonstrate the mitigating effect of CD44s expression on the hepatic metastatic phenotype in a colorectal carcinoma cell line that does not ordinarily express CD44.
|
11724345 |
2001 |